PIM
DGX icon

Penobscot Investment Management’s Quest Diagnostics DGX Stock Holding History

Penobscot Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,430
Closed -$208K – 243
2021
Q3 		$208K Buy
+1,430
New +$209K 0.03% 231

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Penobscot Investment Management's DGX Position: Q4 2021 in Review

Penobscot Investment Management sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 1,430 shares — an estimated $208K sold.

Penobscot Investment Management first reported a position in DGX in Q3 2021 and held it in 1 quarter. The position peaked at $208K in Q3 2021. 906 funds tracked by Wall St. Rank hold DGX as of Q4 2021.

  • Penobscot Investment Management reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Penobscot Investment Management sold 1,430 Quest Diagnostics shares in Q4 2021, an estimated $208K.
  • Penobscot Investment Management first reported a position in Quest Diagnostics in Q3 2021 and held it in 1 quarter.
  • Penobscot Investment Management's Quest Diagnostics position peaked at $208K in Q3 2021.
  • 906 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.

Based on Penobscot Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.